Callahan Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14M | Buy |
17,972
+1,312
| +8% | +$1.02M | 1.26% | 28 |
|
|
2025
Q1 | $13.8M | Buy |
16,660
+2,326
| +16% | +$1.92M | 1.31% | 28 |
|
|
2024
Q4 | $11.1M | Sell |
14,334
-547
| -4% | -$422K | 1.04% | 33 |
|
|
2024
Q3 | $13.2M | Buy |
14,881
+301
| +2% | +$267K | 1.28% | 25 |
|
|
2024
Q2 | $13.2M | Buy |
14,580
+2,477
| +20% | +$2.24M | 1.37% | 26 |
|
|
2024
Q1 | $9.42M | Buy |
12,103
+1,661
| +16% | +$1.29M | 0.99% | 35 |
|
|
2023
Q4 | $6.09M | Buy |
10,442
+2,663
| +34% | +$1.55M | 0.71% | 49 |
|
|
2023
Q3 | $4.18M | Buy |
7,779
+6,749
| +655% | +$3.63M | 0.52% | 54 |
|
|
2023
Q2 | $483K | Buy |
1,030
+150
| +17% | +$70.3K | 0.06% | 108 |
|
|
2023
Q1 | $302K | Sell |
880
-10
| -1% | -$3.43K | 0.04% | 123 |
|
|
2022
Q4 | $326K | Buy |
890
+90
| +11% | +$32.9K | 0.04% | 121 |
|
|
2022
Q3 | $259K | Sell |
800
-50
| -6% | -$16.2K | 0.04% | 131 |
|
|
2022
Q2 | $276K | Buy |
850
+25
| +3% | +$8.12K | 0.04% | 132 |
|
|
2022
Q1 | $236K | Sell |
825
-25
| -3% | -$7.15K | 0.03% | 140 |
|
|
2021
Q4 | $235K | Buy |
+850
| New | +$235K | 0.03% | 141 |
|